Lupin receives FDA approval for Rosuvastatin Calcium tablets
The medicine is indicated for the treatment of adult patients with hypertriglyceridemia
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Lupin Laboratories
Lupin posts net profit at Rs 3,581 mn in Q1 FY 2018
EBITDA for the quarter was Rs 8,003 million compared to Rs 8,267 million in Q4 FY 2017
Lupin receives FDA approval for generic Flucytosine caps
Flucytosine capsules is a generic version of Valeant Pharmaceuticals International's Ancobon Capsules
Lupin launches generic Vigamox Ophthalmic solution in the US
The product is being manufactured at the company's Pithampur facility
Lupin completes acquisition of Pharma Dynamics
PD will become a wholly-owned subsidiary of Lupin, subject to closing conditions